1. Home
  2. TELA vs CHGG Comparison

TELA vs CHGG Comparison

Compare TELA & CHGG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TELA
    SELLHOLDBUYas of 2 days ago
  • CHGG
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • TELA 2012
  • CHGG 2005
  • Country
  • TELA United States
  • CHGG United States
  • Employees
  • TELA N/A
  • CHGG N/A
  • Industry
  • TELA Medical/Dental Instruments
  • CHGG Other Consumer Services
  • Sector
  • TELA Health Care
  • CHGG Real Estate
  • Exchange
  • TELA Nasdaq
  • CHGG Nasdaq
  • Market Cap
  • TELA 92.2M
  • CHGG N/A
  • IPO Year
  • TELA 2019
  • CHGG 2013
  • Fundamental
  • Price
  • TELA $1.24
  • CHGG $0.66
  • Analyst Decision
  • TELA Strong Buy
  • CHGG Sell
  • Analyst Count
  • TELA 4
  • CHGG 7
  • Target Price
  • TELA $6.00
  • CHGG $2.08
  • AVG Volume (30 Days)
  • TELA 427.2K
  • CHGG 3.4M
  • Earning Date
  • TELA 03-20-2025
  • CHGG 04-28-2025
  • Dividend Yield
  • TELA N/A
  • CHGG N/A
  • EPS Growth
  • TELA N/A
  • CHGG N/A
  • EPS
  • TELA N/A
  • CHGG N/A
  • Revenue
  • TELA $69,300,000.00
  • CHGG $617,574,000.00
  • Revenue This Year
  • TELA $38.03
  • CHGG N/A
  • Revenue Next Year
  • TELA $24.38
  • CHGG N/A
  • P/E Ratio
  • TELA N/A
  • CHGG N/A
  • Revenue Growth
  • TELA 18.56
  • CHGG N/A
  • 52 Week Low
  • TELA $1.15
  • CHGG $0.62
  • 52 Week High
  • TELA $6.50
  • CHGG $7.75
  • Technical
  • Relative Strength Index (RSI)
  • TELA 20.75
  • CHGG 32.99
  • Support Level
  • TELA $1.15
  • CHGG $0.69
  • Resistance Level
  • TELA $1.37
  • CHGG $0.77
  • Average True Range (ATR)
  • TELA 0.19
  • CHGG 0.07
  • MACD
  • TELA -0.10
  • CHGG 0.01
  • Stochastic Oscillator
  • TELA 6.75
  • CHGG 16.50

Stock Price Comparison Chart: TELA vs CHGG

TELA
CHGG
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090100TELA VS CHGG

About TELA TELA Bio Inc.

TELA Bio Inc is a United States-based medical technology company. The company is involved in developing and marketing of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. Its reinforced tissue matrices called OviTex improve the clinical outcomes and reduce costs of care in hernia repair, abdominal wall reconstruction and plastic and reconstructive surgery. The company's second portfolio of products, the OviTex PRS Reinforced Tissue Matrix, addresses unmet needs in plastic and reconstructive surgery.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use